About Glaxosmithkline Pharmaceuticals Ltd
GlaxoSmithKline Pharmaceuticals is engaged interalia, in the business of manufacturing, distributing and trading in pharmaceuticals.
Founded
1924
CEO
Renu S. Karnad
Employees
3,103
HQ
Mumbai, Maharashtra
Finished Products
1Sales
₹17,209.61Cr2Other Operating Revenue
₹145.18CrRaw Materials
1Purchases of Traded Goods
₹4,126.50Cr2Raw Materials Consumed
₹2,322.74CrAbout Glaxosmithkline Pharmaceuticals Ltd
GlaxoSmithKline Pharmaceuticals is engaged interalia, in the business of manufacturing, distributing and trading in pharmaceuticals.
Founded:1924
CEO:Renu S. Karnad
Employees:3,103
HQ:Mumbai, Maharashtra
Finished Products
1Sales
₹17,209.61Cr2Other Operating Revenue
₹145.18CrRaw Materials
1Purchases of Traded Goods
₹4,126.50Cr2Raw Materials Consumed
₹2,322.74CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹3,121
52W Low
₹2,088
Volume59.23K
Avg VolumeN/A
Beta0.44
Dividend Yield1.90%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
47.50x
Valuation
P/B Ratio
22.37x
Valuation
EPS
₹63.05
Valuation
Dividend Yield
1.90%
Valuation
ROE
45.69%
Profitability
ROCE
61.23%
Profitability
Revenue by Segment
Contribution & growth by business line
PharmaceuticalsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
98.6%
International
1.4%
India98.6%
Foreign countries1.4%
Strategic Relations
Collaborations, joint ventures & subsidiaries
G
GlaxoSmithKline Plc
United Kingdom
51.00% stakeForensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.01x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
3.4%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.